Adenosine Deaminase

Adenosine Deaminase Products

  • All (5)
  • Adenosine Deaminase Inhibitors (4)
  • Adenosine Deaminase Antagonist (1)
  • New Adenosine Deaminase Products
Catalog No. Product Name Information Product Use Citations Product Validations
S1199 Cladribine Cladribine is an adenosine deaminase inhibitor for U266, RPMI8226, and MM1.S cells with IC50 of approximately 2.43 μM, 0.75 μM, and 0.18 μM, respectively.
Exp Hematol Oncol, 2023, 12(1):23
Neurol Neuroimmunol Neuroinflamm, 2023, 10(5)e200149
Am J Cancer Res, 2023, 13(2):355-378
S9521 Pentostatin Pentostatin(CI-825,Deoxycoformycin) is a potent inhibitor of adenosine deaminase. The drug is effective in the treatment of many lymphoproliferative malignancies, particularly hairy-cell leukemia. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity.
Res Sq, 2023, rs.3.rs-2276903
Nat Metab, 2020, 10.1038/s42255-020-0227-4
E1093 DNPH1i(N6-benzyladenosine) DNPH1i (N6-benzyladenosine,BAPR) is a competitive inhibitor of adenosine deaminase(ADA) from L-1210 cells in axenic culture as well as a potent antiproliferative agent in vitro and in vivo.
S0950 Hibifolin Hibifolin (Gossypetin-8-O-β-D-glucuronide) is a flavonol glycoside and acts as a potential inhibitor of adenosine deaminase (ADA) with a Ki of 49.92 μM. Hibifolin prevents β-amyloid-induced neurotoxicity in cultured cortical neurons.
E4031New 8-Cyclopentyl-1,3-dimethylxanthine 8-Cyclopentyl-1,3-dimethylxanthine is a selective adenosine A1 receptor antagonist with Ki's of 10.9 nM and 1440 nM for A1 receptor and A2 receptor, respectively.
S1199 Cladribine Cladribine is an adenosine deaminase inhibitor for U266, RPMI8226, and MM1.S cells with IC50 of approximately 2.43 μM, 0.75 μM, and 0.18 μM, respectively.
Exp Hematol Oncol, 2023, 12(1):23
Neurol Neuroimmunol Neuroinflamm, 2023, 10(5)e200149
Am J Cancer Res, 2023, 13(2):355-378
S9521 Pentostatin Pentostatin(CI-825,Deoxycoformycin) is a potent inhibitor of adenosine deaminase. The drug is effective in the treatment of many lymphoproliferative malignancies, particularly hairy-cell leukemia. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity.
Res Sq, 2023, rs.3.rs-2276903
Nat Metab, 2020, 10.1038/s42255-020-0227-4
E1093 DNPH1i(N6-benzyladenosine) DNPH1i (N6-benzyladenosine,BAPR) is a competitive inhibitor of adenosine deaminase(ADA) from L-1210 cells in axenic culture as well as a potent antiproliferative agent in vitro and in vivo.
S0950 Hibifolin Hibifolin (Gossypetin-8-O-β-D-glucuronide) is a flavonol glycoside and acts as a potential inhibitor of adenosine deaminase (ADA) with a Ki of 49.92 μM. Hibifolin prevents β-amyloid-induced neurotoxicity in cultured cortical neurons.
E4031New 8-Cyclopentyl-1,3-dimethylxanthine 8-Cyclopentyl-1,3-dimethylxanthine is a selective adenosine A1 receptor antagonist with Ki's of 10.9 nM and 1440 nM for A1 receptor and A2 receptor, respectively.
E4031New 8-Cyclopentyl-1,3-dimethylxanthine 8-Cyclopentyl-1,3-dimethylxanthine is a selective adenosine A1 receptor antagonist with Ki's of 10.9 nM and 1440 nM for A1 receptor and A2 receptor, respectively.

Choose Selective Adenosine Deaminase Inhibitors

Tags: Adenosine Deaminase inhibitor|Adenosine Deaminase agonist|Adenosine Deaminase activator|Adenosine Deaminase inducer|Adenosine Deaminase antagonist|Adenosine Deaminase signaling pathway|Adenosine Deaminase assay kit